Lung Lau, MD
Colon & Rectal Surgery · Poughkeepsie, NYNPI 1326432576
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.5%), education and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Intuitive Surgical at 53.7% of the total. Reporting peaked in 2024 at $2,363 and has fallen 56.3% since, to $1,034 in 2025.
Across 36 payments — averaging $117.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$2K
- THD America, Inc.$780
- Medtronic$487
- Boston Scientific$397
- Aroa Biosurgery Incorporated$205
- Smith+Nephew$45
- plus $43 from 2 others
What the payments were for
- Travel & lodging$2,38856%
- Food & beverage$84220%
- Education$1,00024%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 10 | $2,273 |
| THD America, Inc. | 5 | $780 |
| Medtronic | 7 | $487 |
| Boston Scientific | 8 | $397 |
| Aroa Biosurgery Incorporated | 2 | $205 |
| Smith+Nephew | 2 | $45 |
| Solventum Corporation | 1 | $23 |
| Johnson & Johnson | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$1,181
- DAVINCI XI$1,000
- Signia$219
How this compares
$4,230 in reported general payments places this provider in the 65th percentile of 177 colon & rectal surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 22 | $85 |
| Neomycin Sulfate | 15 | $75 |
| Metronidazole | 15 | $29 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Poughkeepsie
- David RivadeneiraWoodbury$271K
- Jerald WishnerMount Kisco$246K
- Sanghyun KimNew York$154K
- Ziad KronfolWest Nyack$81K
- Lynn OconnorHuntington$63K
- Mehraneh JafariNew York$50K
- Jeffrey MilsomNew York$42K
- Stephen RauhRochester$37K
- Evelyn IrizarryBronx$26K
- David SchwartzbergNew York$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.